Peter Belden
Pete Belden is President for ICS, a part of AmerisourceBergen, where he has strategic management and operational responsibility for the leading provider of third-party logistics for healthcare. ICS’ sister company, World Courier, serves as the logistics partner for Novartis’ Kymriah.
Belden previously served in several leadership roles with AndersonBrecon, which was part of AmerisourceBergen from 2003 until its sale to PCI in 2013. At AndersonBrecon, Belden established a track record for driving company growth in each of his executive roles: Vice President, Sales & Marketing, Senior Vice President & Managing Director and Senior Vice President of Commercial Services. Following AndersonBrecon's sale to PCI, he served as Vice President & General Manager, where he led the two companies' integration and oversaw operations to ensure business continuity.
-
The challenges gene therapies pose for logistics
By Peter Belden
Manufacturers must carefully consider the integrated logistics required to bring therapies like Kymriah and Yescarta to market, a process requiring more coordination than the commercialization of traditional therapies.
Share/ Oct 20, 2017 at 7:59 AM
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
MedCity >> Inbox
Get the latest industry news first when you subscribe to our newsletter.
We will never sell or share your information without your consent. See our privacy policy.Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.